Bordetella hinzii Genomic Characteristics and Vaccine Target Discovery

Abstract

Objective: This study was aimed at analyzing the pathogenic characteristics of Bordetella hinzii (B. hinzii), and elucidating its antibiotic resistance mechanisms, virulence gene distribution, and vaccine development potential.

Methods: Genomes of 38 global strains were downloaded from the NCBI database. After quality control with CheckM, pan-genome analysis was performed with Roary, SNP-based phylogenetic trees were constructed with snippy, and antibiotic resistance genes (CARD database) and virulence genes (VFDB database) were predicted with abricate. Bioinformatics tools were integrated to screen candidate vaccine proteins.

Results: All strains carried intrinsic resistance genes, including efflux pumps (MexAB-OprM) and the β-lactamase HBL-1, which conferred resistance to ten antibiotic classes. Core virulence genes (bplA-L, bvgAS, and flagella-associated genes) were highly conserved (detection rate >92.1%). SNP analysis classified the strains into six clades, and human-derived isolates showed host-specific clustering. The pan-genome was open (7,530 genes; Heaps’ law parameter B = 0.35). Two outer membrane proteins, LptD and BamD, were identified as vaccine candidates (antigenicity scores >0.4; no host homology).

Conclusion: B. hinzii exhibits cross-host transmission risks, driven by conserved virulence genes and an open genome enabling adaptive evolution. LptD and BamD represent potential vaccine targets requiring further validation. This study provides a theoretical basis for clinical management and prevention strategies.

Keywords

Bordetella hinzii / Multidrug resistance / Virulence genes / Pan-genome / Vaccine development

References

[1] Launay A, Wu C-J, Dulanto Chiang A, Youn J-H, Khil PP, Dekker JP. In vivo evolution of an emerging zoonotic bacterial pathogen in an immunocompromised human host. Nat Commun. 2021; 12: 4495.

[2] Ben Lakhal H, Cachinho JB, Kalfon P, Naas T, Benseddik Z. Bordetella hinzii pneumonia in patient with SARS-CoV-2 infection . Emerg Infect Dis. 2022; 28(4): 844-847.

[3] Wang GC, Wallace MJ, Krishnan G, Olson PD, Carlson AL, Dantas G, et al. Spontaneous bacterial peritonitis caused by Bordetella hinzii . Emerg Infect Dis. 2021; 27(11): 2966-2968.

[4] Liu Y, Zhu R, Liu X, Li D, Guo M, Fei B, et al. Effect of piperine on the inhibitory potential of MexAB-OprM efflux pump and imipenem resistance in carbapenem-resistant Pseudomonas aeruginosa. Microb Pathog. 2023; 185: 106397.

[5] Niinikoski V, Barkoff AM, Mertsola J, Holubova J, Masin J, Sebo P, et al. Alterations in the expression of Bordetella pertussis antigens in relation to the use of acellular pertussis vaccine in Finland . Vaccine. 2025; 58: 127279.

[6] Ota N, Nishida T, Standley DM, Sherif AA, Iwano S, Nugraha DK, et al. Lonidamine, a novel modulator for the BvgAS system of Bordetella species . Microbiol Immunol. 2024, 69(3): 133-147.

[7] D’Halluin A, Petrácková D, Curnová I, Držmíšek J, Capek J, Bouquet P, et al. An IS element-driven antisense RNA attenuates the expression of serotype 2 fimbriae and the cytotoxicity of Bordetella pertussis . Emerg Microbes Infect. 2025; 14(1): 2451718.

[8] Zhang L, Zheng Z, Zhang Y, Wu X, Tu Y, Liu C, et al. Chemical synthesis and antigenic evaluation of oligosaccharides of Bordetella hinzii O-antigen containing unique amidated 2,3-diacetamido-2,3-dideoxy-alduronic acids . JACS Au. 2025; 5(4): 1903-1913.

[9] Noori Goodarzi N, Barzi SM, Ajdary S, Chiani M, Yekaninejad MS, Badmasti F, et al. Immunogenic evaluation of LptD + LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae. J Transl Med. 2025; 23(1): 261.

[10] Dawood AA. Designing an immuno-epitope candidate vaccine from (Opa, ProA, ProB, RmpM and BamD) proteins against Neisseria gonorrhoeae and Neisseria meningitides . Vacunas. 2024; 25(4): 481-491.

[11] Wang Y, Cheng Y, Li Y, Wang Y, Fu X. Rationally designed self-derived peptides kill Escherichia coli by targeting BamA and BamD essential for outer membrane protein biogenesis . ACS Infect Dis. 2025; 11(5): 1092-1103.

[12] Kampmeier S, Rennebaum F, Schmidt H, Riegel A, Herrmann M, Schaumburg F. Peripancreatic abscess supported by Bordetella hinzii . New Microbes New Infect. 2020; 34: 100650.

[13] Vulturar DM, Pilmis B, Rouzaud C, Gigandon A, Dauriat G, Feuillet-Soummer S, et al. Uncovering the unseen: Bordetella hinzii emerges in a lung transplant recipient . Int J Mol Sci. 2024; 25(9): 4708.

[14] Loong SK, Liam CK, Karunakaran R, Tan KK, Mahfodz NH, AbuBakar S. Non-classical Bordetella sp. (closely related to Bordetella hinzii and Bordetella pseudohinzii) lower respiratory tract infection in a patient with extensive bronchiectasis: a case report . J Int Med Res. 2024; 52(1): 3000605231214464.

[15] Wang L, Yao X, He F, Lv J, Zhou H, Li Q. Pneumonia caused by Bordetella hinzii: a case report . Infect Med. 2025; 4(2): 100182.

[16] Sparks R, Painter A, Callum J, Swan C, Polkinghorne A, Fong W, et al. Detection and characterisation of Bordetella hinzii in line-related bacteraemia and respiratory tract infection in Australia . Pathology. 2023; 55(1): 117-122.